Direxion Daily LLY Bear 1X Shares (NASDAQ:ELIS) Trading 1.3% Higher – Time to Buy?

Shares of Direxion Daily LLY Bear 1X Shares (NASDAQ:ELIS) were up 1.3% on Wednesday . The company traded as high as $18.40 and last traded at $18.06. Approximately 10,500 shares changed hands during mid-day trading, an increase of 18% from the average daily volume of 8,888 shares. The stock had previously closed at $17.82.

Direxion Daily LLY Bear 1X Shares Trading Up 1.3%

The business has a 50-day simple moving average of $17.81 and a 200-day simple moving average of $22.40.

Direxion Daily LLY Bear 1X Shares Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, December 31st. Shareholders of record on Tuesday, December 23rd were given a dividend of $0.6173 per share. The ex-dividend date of this dividend was Tuesday, December 23rd. This represents a $2.47 dividend on an annualized basis and a yield of 13.7%. This is a positive change from Direxion Daily LLY Bear 1X Shares’s previous quarterly dividend of $0.17.

Institutional Investors Weigh In On Direxion Daily LLY Bear 1X Shares

Several hedge funds and other institutional investors have recently made changes to their positions in ELIS. Optiver Holding B.V. lifted its position in shares of Direxion Daily LLY Bear 1X Shares by 541.3% during the 3rd quarter. Optiver Holding B.V. now owns 73,489 shares of the company’s stock worth $1,863,000 after purchasing an additional 62,030 shares during the last quarter. Goldman Sachs Group Inc. acquired a new stake in Direxion Daily LLY Bear 1X Shares in the 1st quarter valued at approximately $645,000. Finally, Csenge Advisory Group bought a new position in Direxion Daily LLY Bear 1X Shares in the 3rd quarter worth approximately $411,000.

Direxion Daily LLY Bear 1X Shares Company Profile

Direxion Shares ETF Trust – Direxion Daily LLY Bear 1X Shares is an exchange traded fund launched by Direxion Investments. The fund is managed by Rafferty Asset Management, LLC. It invests in public equity markets. It invests through derivatives in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund employs short strategy and uses derivatives such as swaps and options to create its portfolio. The fund invests in growth and value stocks of companies across diversified market capitalization.